Month: <span>April 2017</span>

Home / 2017 / April
Post

Dizziness inPparkinson’s may be due to cerebral hypoperfusion

(HealthDay)—Cerebral hypoperfusion contributes to dizziness in patients with Parkinson’s disease (PD), even without orthostatic hypotension (OH), according to a study published online April 12 in the Journal of Clinical Ultrasound. Jinse Park, M.D., from Inje University in Busan, South Korea, and colleagues conducted transcranial Doppler and blood pressure monitoring for 10 minutes during the head-up tilt...

Post

Academia, industry collaborate on solutions to neural disease, injury

Neurological disorders like Parkinson’s, the aftermath of stroke, limb loss and paralysis significantly diminish the length and quality of life — affecting about one in six people worldwide. But a growing number of biomedical innovations, driven in large part by an aging population dealing with debilitating health issues, are improving both cognitive and motor function....

Post

Discovery of new T-cell subtype opens window on rheumatoid arthritis

Finding flows from researchers’ use of high-tech tools to deeply and efficiently characterize patient cells Rheumatoid arthritis is an autoimmune condition in which the immune system attacks the joints, causing inflammation, pain, and eventually destruction of the tissues that make up this essential body part. A research team led by scientists from Brigham and Women’s...

Post

Dragon blood may help wounds heal faster

A bacteria-fighting compound, based on a molecule from Komodo dragon blood, helped wounds heal faster in mice. In some myths, dragon’s blood is a toxic, vile substance. In others, it has magical properties, curing disease and making ordinary mortals invincible. When it comes to the blood of real-life Komodo dragons, both perspectives may contain a kernel...

Post

Ground-breaking app offering personalised rehabilitation programs for patients following stroke

Micrograph showing cortical pseudolaminar necrosis, a finding seen in strokes on medical imaging and at autopsy. H&E-LFB stain.   Stroke is one of the world’s leading causes of disability so a first-of-its-kind app that supports clinicians to develop best practice rehabilitation strategies for patients with arm impairments following stroke is good news for millions of...

Post

New approach makes cells resistant to HIV

Scientists at The Scripps Research Institute (TSRI) have found a way to tether HIV-fighting antibodies to immune cells, creating a cell population resistant to the virus. Their experiments under lab conditions show that these resistant cells can quickly replace diseased cells, potentially curing the disease in a person with HIV. “This protection would be long term,”...

Post

Potential new treatment to treat and stop progression of cystic fibrosis

Cystic fibrosis is a genetic disease that causes persistent lung infections and limits the ability to breathe over time. Researchers from the George Washington University (GW), the University of Perugia, and the University of Rome have discovered a potential new drug to treat and stop the progression of cystic fibrosis. Thymosin α1 (Tα1) is a...

Post

Stanford lab grows cornea cells for transplant

PALO ALTO — A Stanford research team has created a potentially powerful new way to fix damaged corneas — a major source of vision problems and blindness. Millions of new eye cells are being grown in a Palo Alto lab, enlisting one of medicine’s most important and promising new tools: refurbishing diseased and damaged tissue...